Anthony Polverino

2019 - Zymeworks

In 2019, Anthony Polverino earned a total compensation of $1.3M as Former Executive VP, Early Development & Chief Scientific Officer at Zymeworks.

Compensation breakdown

Non-Equity Incentive Plan$178,000
Option Awards$758,019
Salary$400,000
Other$384
Total$1,336,403

Polverino received $758K in option awards, accounting for 57% of the total pay in 2019.

Polverino also received $178K in non-equity incentive plan, $400K in salary and $384 in other compensation.

Rankings

In 2019, Anthony Polverino's compensation ranked 7,897th out of 13,971 executives tracked by ExecPay. In other words, Polverino earned more than 43.5% of executives.

ClassificationRankingPercentile
All
7,897
out of 13,971
44th
Division
Manufacturing
3,111
out of 5,695
45th
Major group
Chemicals And Allied Products
1,175
out of 2,194
46th
Industry group
Drugs
1,004
out of 1,880
47th
Industry
Pharmaceutical Preparations
745
out of 1,392
47th
Source: SEC filing on November 25, 2022.

Polverino's colleagues

We found three more compensation records of executives who worked with Anthony Polverino at Zymeworks in 2019.

2019

Ali Tehrani

Zymeworks

Chief Executive Officer

2019

Neil Klompas

Zymeworks

Chief Financial Officer

2019

Diana Hausman

Zymeworks

Chief Medical Officer

News

In-depth

You may also like